Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIDA2: IV vs Oral Iron for Iron-Deficiency Anemia in Pregnancy
NCT05462704Phase 3Recruiting
- Sponsor
- Women & Infants Hospital
- Start
- Jan 2023
- Primary completion
- Mar 2027
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Women & Infants Hospital. Started Jan 2023; status: recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05462704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05462704.